OLRATAN CP 20/10 TABLET

Product Description

OLRATAN CP 20/10 TABLET is a clinically effective antihypertensive formulation, combining Olmesartan Medoxomil 20mg (an angiotensin II receptor blocker) with Cilnidipine 10mg (a calcium channel blocker). This dual-action therapy ensures optimal blood pressure control, reduced cardiovascular risk, and improved patient compliance making it a preferred choice in hypertension management.

Designed for pharmaceutical distributors, hospital procurement teams, and bulk medicine buyers, OLRATAN CP 20/10 offers reliable therapeutic results, quality assurance, and attractive trade margins.

Key Benefits:

• Dual antihypertensive action for superior blood pressure regulation

• Minimizes the risk of stroke, heart attack, and kidney complications

• Well-tolerated with once-daily dosing for better patient adherence

• Manufactured under WHO-GMP certified facilities ensuring high-quality standards

Applications:

• Recommended in the treatment of essential hypertension

• Ideal for patients with co-existing cardiovascular risks

• Commonly prescribed in cardiology, general medicine, and internal medicine

Why Choose OLRATAN CP 20/10 TABLET?

• Effective combination therapy for long-term hypertension control

• Suitable for bulk supply, institutional tenders, and private label inquiries

• Fast-moving product in the cardiovascular medicine segment